No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Distribution
China National Accord Medicines Corporation Ltd. primarily focuses on the wholesale and retail distribution of a wide array of pharmaceutical and medical products. The company's extensive product offerings include traditional Chinese remedies, advanced biochemical and biological medicines, diagnostic agents, and antibiotics. Additionally, it supplies various chemical preparations, food items, industrial chemicals, and a diverse range of other general commodities. Beyond its core sales activities, the company is involved in selling medical apparatus and instruments. It offers comprehensive logistics services, encompassing freight transportation, warehousing, and cargo handling, alongside professional consulting. Further diversifying its operations, it markets glassware, cosmetics, and daily necessities, and provides goods agency services. The firm also participates in the import and export of technology, leases properties, and engages in the wholesale and retail of health-related products. As of December 31, 2021, China National Accord Medicines managed a significant network of 8,798 drugstores across 20 provinces, autonomous regions, and municipalities within China. This expansive retail footprint included 7,257 directly owned stores and 1,541 franchised locations. Established in 2004 and based in Shenzhen, China, the company operates as a subsidiary of Sinopharm Group Co., Ltd.
www.szaccord.com.cnNo one on the platform currently holds 000028.SZ.
No tracked institution reports a position in 000028.SZ as of their last filing.
No one on the platform has traded 000028.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 5.0% | 7.6% | 12.9% | — | — | — |
| Rev. Growth % | -1.5% | 4.2% | ||||
| Profit Margin % | 1.5% | 1.7% | 2.2% | |||
| Free Cash Flow Margin % | 2.1% | 2.9% | 2.8% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $75.7B | +0.6% | $1.94 | $1.89–$1.99 | — | 3 |
| 2027 | $77.9B | +2.9% | $2.01 | $1.81–$2.14 | — | 4 |
| 2028 | $77.9B | -0.1% | $1.97 | $1.91–$2.04 | — | 2 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-29 | $0.53 | $0.52 | -1.9% |
| 2026-04-21 | $0.47 | $0.47 | -0.6% |
| 2026-03-17 | $0.42 | $0.29 | -30.7% |
| 2025-10-21 | $0.56 | $0.47 | -14.8% |
| 2025-08-14 | $0.51 | $0.61 | +19.8% |
| 2025-04-25 | $0.56 | $0.59 | +6.3% |
| 2025-03-18 | $0.61 | $-0.76 | -224.8% |
| 2024-10-28 | $0.62 | $0.57 | -8.1% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 000028.SZChina National Accord Medicines Corporation Ltd. | $19.80 | +0.00% | $10.6B | — |
| 002287.SZTibet Cheezheng Tibetan Medicine Co., Ltd. | $19.10 | +0.00% | $10.9B | — |
| 002626.SZXiamen Kingdomway Group Company | $16.08 | -0.37% | $9.8B | — |
| 301015.SZQingdao Baheal Medical Inc. | $23.32 | -0.81% | $12.3B | — |
| 600056.SSChina Meheco Group Co., Ltd. |
| $8.85 |
| -0.34% |
| $13.2B |
| — |
| 600267.SSZhejiang Hisun Pharmaceutical Co., Ltd. | $11.28 | -0.18% | $13.3B | — |
| 600750.SSChina Resources Jiangzhong Pharmaceutical Co.,Ltd | $22.06 | +0.00% | $14.0B | — |
Source: Financial Modeling Prep · peers by sector/industry